{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:38:59Z","timestamp":1787009939148,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>\n                    Cutaneous melanoma is the most common cause of skin cancer-related deaths worldwide. There is an urgent need to identify prognostic biomarkers to facilitate decision-making for treatment of metastatic cutaneous melanoma. Gene expression microarrays and RNA-seq technology have recently improved or changed current prognostic and therapeutic strategies for several cancers. However, according to the current melanoma staging system, prognosis is almost entirely dependent on clinicopathological features. To identify novel prognostic biomarkers, we investigated gene expression and clinical data for patients with cutaneous melanoma from three cohorts of The Cancer Genome Atlas and Gene Expression Omnibus. Kaplan\u2013Meier survival analysis using median values of each gene as cutoff value revealed that nine genes (\n                    <jats:italic toggle=\"yes\">ABCC3<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CAPS2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CCR6<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CDCA8<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CLU<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">DPF1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PTK2B<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">SATB1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">SYNE1<\/jats:italic>\n                    ) were statistically significant prognostic biomarkers of metastatic cutaneous melanoma in all three independent cohorts. Low expression of two genes (\n                    <jats:italic toggle=\"yes\">CDCA8<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">DPF1<\/jats:italic>\n                    ) and high expression of seven genes (\n                    <jats:italic toggle=\"yes\">ABCC3<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CAPS2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CCR6<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CLU<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PTK2B<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">SATB1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">SYNE<\/jats:italic>\n                    ) were significantly associated with positive metastatic cutaneous melanoma prognoses. In conclusion, we suggest nine novel prognostic biomarkers for cutaneous metastatic melanoma.\n                  <\/jats:p>","DOI":"10.1097\/cmr.0000000000000697","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T01:00:08Z","timestamp":1601514008000},"page":"543-547","source":"Crossref","is-referenced-by-count":10,"title":["Identification of prognostic mRNAs in metastatic cutaneous melanoma"],"prefix":"10.1097","volume":"30","author":[{"given":"Soohwan","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hie Bum","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Radiology, School of Medicine, Pusan National University"},{"name":"Biomedical Research Institute, Pusan National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Ji","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junho","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Wan","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak-Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hak","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics"},{"name":"Department of Anatomy, School of Medicine, Pusan National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyuk","family":"Shin","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, Pusan National University Hospital"},{"name":"Department of Dermatology"},{"name":"Department of Dermatology, Pusan National University Yangsan Hospital"},{"name":"Research Institute for Convergence of Biomedical Science and Technology, Yangsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"R1-20230902","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00428-013-1526-x","article-title":"Tissue prognostic biomarkers in primary cutaneous melanoma.","volume":"464","author":"Mandala","year":"2014","journal-title":"Virchows Arch"},{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdermsci.2011.06.007","article-title":"Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.","volume":"64","author":"Chen","year":"2011","journal-title":"J Dermatol Sci"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma.","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma.","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrclinonc.2015.123","article-title":"Precision medicine for metastatic breast cancer \u2013 limitations and solutions.","volume":"12","author":"Arnedos","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/jid.2011.305","article-title":"Review and cross-validation of gene expression signatures and melanoma prognosis.","volume":"132","author":"Schramm","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R8-20230902","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways.","volume":"455","year":"2008","journal-title":"Nature"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2147\/OTT.S202101","article-title":"Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma.","volume":"12","author":"Goh","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R10-20230902","first-page":"4614","article-title":"Evaluation of the prognostic significances of \u03b3-secretase genes in pancreatic cancer.","volume":"17","author":"Jeon","year":"2019","journal-title":"Oncol Lett"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"15608","DOI":"10.1038\/s41598-018-34129-9","article-title":"SAC3D1: a novel prognostic marker in hepatocellular carcinoma.","volume":"8","author":"Han","year":"2018","journal-title":"Sci Rep"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/jcb.27645","article-title":"Prognostic role of TPD52 in acute myeloid leukemia: a retrospective multicohort analysis.","volume":"120","author":"Ha","year":"2019","journal-title":"J Cell Biochem"},{"key":"R14-20230902","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/jcmm.14208","article-title":"Development of a risk scoring system for patients with papillary thyroid cancer.","volume":"23","author":"Pak","year":"2019","journal-title":"J Cell Mol Med"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature06781","article-title":"SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.","volume":"452","author":"Han","year":"2008","journal-title":"Nature"},{"issue":"Pt 4","key":"R16-20230902","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1242\/jcs.00892","article-title":"A role for the spectrin superfamily member Syne-1 and kinesin II in cytokinesis.","volume":"117","author":"Fan","year":"2004","journal-title":"J Cell Sci"},{"key":"R17-20230902","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1006\/bbrc.1996.1595","article-title":"Molecular cloning and RNA expression of two new human chemokine receptor-like genes.","volume":"227","author":"Zaballos","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-20230902","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc2967","article-title":"Integrin signalling adaptors: not only figurants in the cancer story.","volume":"10","author":"Cabodi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R19-20230902","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.cdd.4401779","article-title":"Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.","volume":"13","author":"Shannan","year":"2006","journal-title":"Cell Death Differ"},{"key":"R20-20230902","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(02)00920-4","article-title":"Genomic structure of the sponge, halichondria okadai calcyphosine gene.","volume":"298","author":"Yuasa","year":"2002","journal-title":"Gene"},{"key":"R21-20230902","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/mmr.2017.6194","article-title":"Identification of prognostic genes in kidney renal clear cell carcinoma by RNA-seq data analysis.","volume":"15","author":"Gu","year":"2017","journal-title":"Mol Med Rep"},{"key":"R22-20230902","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1189\/jlb.0309147","article-title":"ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.","volume":"86","author":"van de Ven","year":"2009","journal-title":"J Leukoc Biol"},{"key":"R23-20230902","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2007.06.019","article-title":"An essential switch in subunit composition of a chromatin remodeling complex during neural development.","volume":"55","author":"Lessard","year":"2007","journal-title":"Neuron"},{"key":"R24-20230902","first-page":"404","article-title":"Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.","volume":"43","author":"Ci","year":"2019","journal-title":"Int J Mol Med"},{"key":"R25-20230902","first-page":"2707","article-title":"Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro.","volume":"26","author":"Shannan","year":"2006","journal-title":"Anticancer Res"},{"key":"R26-20230902","first-page":"6231","article-title":"Overexpression of calcyphosine is associated with poor prognosis in esophageal squamous cell carcinoma.","volume":"14","author":"Li","year":"2017","journal-title":"Oncol Lett"},{"key":"R27-20230902","doi-asserted-by":"crossref","first-page":"30657","DOI":"10.1074\/jbc.274.43.30657","article-title":"Negative regulation of PYK2\/related adhesion focal tyrosine kinase signal transduction by hematopoietic tyrosine phosphatase SHPTP1.","volume":"274","author":"Kumar","year":"1999","journal-title":"J Biol Chem"},{"key":"R28-20230902","doi-asserted-by":"crossref","first-page":"e7012","DOI":"10.1371\/journal.pone.0007012","article-title":"Distinct high-profile methylated genes in colorectal cancer.","volume":"4","author":"Mokarram","year":"2009","journal-title":"PLoS One"},{"key":"R29-20230902","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature08139","article-title":"MicroRNA-mediated switching of chromatin-remodelling complexes in neural development.","volume":"460","author":"Yoo","year":"2009","journal-title":"Nature"},{"key":"R30-20230902","doi-asserted-by":"crossref","first-page":"e1108513","DOI":"10.1080\/2162402X.2015.1108513","article-title":"The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.","volume":"5","author":"Pessina","year":"2016","journal-title":"Oncoimmunology"},{"key":"R31-20230902","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.imbio.2019.01.005","article-title":"The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.","volume":"224","author":"Lee","year":"2019","journal-title":"Immunobiology"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:06:16Z","timestamp":1693613176000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000697","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}